Walgreens Boots Alliance has agreed to a $192.5 million settlement in a class action lawsuit brought by investors in Rite Aid who alleged that Walgreens had misled them in 2017 concerning the scrutiny surrounding the proposed merger of the two drugstore giants, per Reuters.
The agreement, which was submitted to Pennsylvania federal court on Wednesday, is contingent upon approval by District Judge Jennifer Wilson.
The lawsuit, which centered on statements made by Walgreens and its executives about the intended merger of the two prominent U.S. pharmacy chains, first announced in 2015, was described by David Knotts, an attorney for the shareholders, as an “intensely fought” case. “We’re very pleased with the result and look forward to the court’s review,” Knotts commented.
Related: US: Walgreens scraps Rite Aid deal, buys stores instead
The lawsuit specifically accused Walgreens of minimizing the attention from U.S. antitrust regulators, a practice that allegedly commenced in October 2016. Ultimately, in June 2017, Walgreens abandoned the takeover plan after failing to secure approval from the Federal Trade Commission. Instead, they opted to purchase roughly 42% of Rite Aid’s existing stores for $4.38 billion that same year.
This settlement comes at a time when Rite Aid is grappling with bankruptcy protection due to substantial debt and costs stemming from opioid litigation.
Source: Reuters
Featured News
Subscribers Defend $4.7 Billion Antitrust Verdict Against NFL in Court Filings
Jul 19, 2024 by
CPI
Von der Leyen Calls for Competition Policy to Boost EU Companies’ Growth
Jul 19, 2024 by
CPI
Vermont AG Sues Pharmacy Benefit Managers Over Drug Prices
Jul 18, 2024 by
CPI
Australians Face Increased Stamp Prices Following ACCC Approval
Jul 18, 2024 by
CPI
Live Nation Seeks Dismissal of DOJ Antitrust Allegations
Jul 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI